Natera Inc (NAS:NTRA)
$ 162.39 0.4 (0.25%) Market Cap: 21.44 Bil Enterprise Value: 20.99 Bil PE Ratio: 0 PB Ratio: 22.95 GF Score: 70/100

Natera Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 08:05PM GMT
Release Date Price: $50.55 (-5.18%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Hey guys. Good afternoon. My name is Tejas Savant, and I'm the life science tools and diagnostics analyst here at Morgan Stanley. It's my pleasure this afternoon to host Natera. And from the company, we have Steve Chapman, CEO; and Mike Brophy, CFO. Thanks, guys, for doing this.

Before we get started, just got to rattle off the disclosures here. Please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your sales rep.

Questions & Answers

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

So with that, Steve, maybe just to set the stage, it's been quite a year for Natera. You are in the headlines for all the wrong reasons earlier in the year. But through it all, you've continued to execute really well on the base business and on the pipeline. And recently, you've got the United decision as well on the PLN. As you look back on a pretty eventful 12 months, what

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot